phillyrin has been researched along with Alcoholic Fatty Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Y; Huang, C; Li, J; Ma, T; Qian, Z; Wang, Z; Zeng, F; Zhang, Y; Zhao, H | 1 |
1 other study(ies) available for phillyrin and Alcoholic Fatty Liver
| Article | Year |
|---|---|
Downregulating PDPK1 and taking phillyrin as PDPK1-targeting drug protect hepatocytes from alcoholic steatohepatitis by promoting autophagy.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Autophagy; Fatty Liver, Alcoholic; Hepatocytes; Humans | 2022 |